EG19424A - Flavolignan derivatives, process for their preparation. - Google Patents

Flavolignan derivatives, process for their preparation.

Info

Publication number
EG19424A
EG19424A EG74085A EG74085A EG19424A EG 19424 A EG19424 A EG 19424A EG 74085 A EG74085 A EG 74085A EG 74085 A EG74085 A EG 74085A EG 19424 A EG19424 A EG 19424A
Authority
EG
Egypt
Prior art keywords
flavolignan
derivatives
preparation
flavolignan derivatives
Prior art date
Application number
EG74085A
Other languages
English (en)
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Application granted granted Critical
Publication of EG19424A publication Critical patent/EG19424A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
EG74085A 1984-11-22 1985-11-21 Flavolignan derivatives, process for their preparation. EG19424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
EG19424A true EG19424A (en) 1995-02-28

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
EG74085A EG19424A (en) 1984-11-22 1985-11-21 Flavolignan derivatives, process for their preparation.

Country Status (29)

Country Link
JP (1) JPS61143377A (xx)
KR (1) KR870001020B1 (xx)
AR (1) AR240931A1 (xx)
AT (1) AT393268B (xx)
BE (1) BE903693A (xx)
CA (1) CA1337124C (xx)
CH (1) CH659473A5 (xx)
CS (1) CS273610B2 (xx)
DD (1) DD259191A1 (xx)
DE (1) DE3442639A1 (xx)
DK (1) DK164865C (xx)
EG (1) EG19424A (xx)
ES (1) ES8609311A1 (xx)
FI (1) FI84064C (xx)
FR (1) FR2573427B1 (xx)
GB (1) GB2167414B (xx)
HU (1) HU195503B (xx)
IE (1) IE58791B1 (xx)
IT (1) IT1190426B (xx)
LU (1) LU86163A1 (xx)
MX (1) MX168415B (xx)
NL (1) NL192387C (xx)
NO (1) NO160205C (xx)
PL (1) PL146890B1 (xx)
PT (1) PT81532B (xx)
SE (1) SE465676B (xx)
SU (1) SU1436875A3 (xx)
YU (1) YU43689B (xx)
ZA (1) ZA858951B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
BRPI0608402B8 (pt) * 2005-03-11 2021-05-25 Armaron Bio Pty Ltd compostos de flavonóide e composições compreendendo os mesmos
CN102300570B (zh) * 2007-11-15 2015-01-14 马道斯有限责任公司 用于治疗肝炎的水飞蓟宾组分
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
CA2761656C (en) * 2009-05-14 2017-02-07 Lucio Claudio Rovati Amorphous silibinin for the treatment of viral hepatitis
AU2013286721B2 (en) 2012-07-05 2018-04-26 Nutramax Laboratories, Inc. Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
FI854535A (fi) 1986-05-23
PT81532A (de) 1985-12-01
CS273610B2 (en) 1991-03-12
IE58791B1 (en) 1993-11-17
LU86163A1 (de) 1986-03-24
GB2167414B (en) 1989-01-11
GB2167414A (en) 1986-05-29
PL256374A1 (en) 1986-12-02
BE903693A (fr) 1986-05-22
FR2573427A1 (fr) 1986-05-23
AR240931A1 (es) 1991-03-27
DK164865C (da) 1993-01-18
CS837885A2 (en) 1990-08-14
DD259191A1 (de) 1988-08-17
NO160205B (no) 1988-12-12
FI854535A0 (fi) 1985-11-18
NL192387B (nl) 1997-03-03
DK537785A (da) 1986-05-23
FI84064B (fi) 1991-06-28
IE852808L (en) 1986-05-22
HUT40114A (en) 1986-11-28
SU1436875A3 (ru) 1988-11-07
ES549116A0 (es) 1986-09-01
YU178685A (en) 1988-02-29
IT8522932A0 (it) 1985-11-21
CH659473A5 (de) 1987-01-30
IT1190426B (it) 1988-02-16
DE3442639C2 (xx) 1989-08-10
FI84064C (fi) 1991-10-10
FR2573427B1 (fr) 1989-03-10
ZA858951B (en) 1986-08-27
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
DK164865B (da) 1992-08-31
DE3442639A1 (de) 1986-05-22
GB8528226D0 (en) 1985-12-18
ATA337185A (de) 1991-02-15
NL192387C (nl) 1997-07-04
SE8505487L (sv) 1986-05-23
YU43689B (en) 1989-10-31
AT393268B (de) 1991-09-25
PT81532B (pt) 1987-11-11
ES8609311A1 (es) 1986-09-01
DK537785D0 (da) 1985-11-21
SE8505487D0 (sv) 1985-11-20
HU195503B (en) 1988-05-30
NO854655L (no) 1986-05-23
MX168415B (es) 1993-05-24
NL8503171A (nl) 1986-06-16
JPS61143377A (ja) 1986-07-01
NO160205C (no) 1989-03-22
AR240931A2 (es) 1991-03-27
KR870001020B1 (ko) 1987-05-23
JPH0432073B2 (xx) 1992-05-28
KR860004056A (ko) 1986-06-16
CA1337124C (en) 1995-09-26

Similar Documents

Publication Publication Date Title
DE3665581D1 (en) 9-halogenprostaglandines, process for their manufacture
EP0181401A4 (en) PROCESS FOR THE PREPARATION OF SOLID PERFUMES.
PT81018B (en) Method for preparing 6-chloro-n-methyl-2,3,4,5-tetrahydro-1h-3--benzazepine
PH23776A (en) Thienopyridinone derivatives,process for their preparation
HUT39735A (en) Process for preparing 1,2-benzisothiazolone derivatives
EG19424A (en) Flavolignan derivatives, process for their preparation.
HUT39168A (en) Process for preparing 1,3-oxazolidin-2-one-derivatives
AU4724385A (en) Elektrodanordning for vattenrenare enligt jonisations- principen, foretradesvis for simbassanger
YU43658B (en) Process for preparing 7,16-dioxa-2-aza-10-0-cladinosyl-12,0-desosaminyl-4,5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)hexadeca-1(2)-ene-8
DE3465193D1 (en) Continuous process for preparing 5-oxo-2,4-dichloro-4-substituted pentanenitriles
EP0173751A4 (en) Method of preparing the capsules.
YU18185A (en) Process for preparing new 1,3,2-dioxaborinanes
EP0174375A4 (en) PRODUCTION PROCESS FOR N-ACYLPHENYLALANINE.
DE3563351D1 (en) Process for the preparation of tetrachloro-benzo-1,4-dioxenes
HUT40088A (en) Process for preparing 8-halogen-5,6-dialkoxy-quinazolin-2,4-dione derivatives
PT80104A (en) Process for preparing 1,2,4-triazacycloalkadiene derivatives
DE3564940D1 (en) Method for preparing 2,2,6,6-tetramethyl-4-oxopiperidine
HUT38906A (en) Process for preparing 1,3-oxyacyl-2-oxindole derivatives
DE3560069D1 (en) Process for preparing 2,6-dichloro-4-nitro-aniline
GB2158434B (en) Process for preparing2,2-bishalomethylpenam derivatives
HUT40426A (en) Process for preparing aromatic 1,4-oxazepinone and -thi-one derivatives
HUT37754A (en) Process for preparing n,3-disubstituted 2-oxindole-1-carboxamide derivatives
EP0227833A4 (en) PROCESS FOR THE PREPARATION OF HETERO-PROTEIN.
HUT40664A (en) Process for producing 7-substituted-2,3-dihydro-bicyclic-pyrazolidinon derivatives
HUT42061A (en) Process for producing alkyl-2-carbalkoxy-3,4-dialkoxy-benzene-carbamate derivatives